SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001615774-17-002090
Filing Date
2017-05-05
Accepted
2017-05-05 16:40:43
Documents
2
Group Members
VIVO VENTURES VII, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G s106075_sc13g.htm SC 13G 67966
2 EXHIBIT 99.1 s106075_ex99-1.htm EX-99.1 4422
  Complete submission text file 0001615774-17-002090.txt   73880
Mailing Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301
Business Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301 (650) 688-0818
Vivo Ventures VI, LLC (Filed by) CIK: 0001469547 (see all company filings)

IRS No.: 208829402 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Subject) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89843 | Film No.: 17818941
SIC: 2834 Pharmaceutical Preparations